Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis.
Southern KW, Castellani C, Lammertyn E, Smyth A, VanDevanter D, van Koningsbruggen-Rietschel S, Barben J, Bevan A, Brokaar E, Collins S, Connett GJ, Daniels TWV, Davies J, Declercq D, Gartner S, Gramegna A, Hamilton N, Hauser J, Kashirskaya N, Kessler L, Lowdon J, Makukh H, Martin C, Morrison L, Nazareth D, Noordhoek J, O'Neill C, Owen E, Oxley H, Raraigh KS, Raynal C, Robinson K, Roehmel J, Schwarz C, Sermet I, Shteinberg M, Sinha I, Takawira C, van Mourik P, Verkleij M, Waller MD, Duff A. Southern KW, et al. Among authors: davies j. J Cyst Fibros. 2023 Jan;22(1):17-30. doi: 10.1016/j.jcf.2022.10.002. Epub 2022 Oct 28. J Cyst Fibros. 2023. PMID: 36916675 Free article.
Prospects for gene therapy for cystic fibrosis.
Davies JC, Geddes DM, Alton EW. Davies JC, et al. Mol Med Today. 1998 Jul;4(7):292-9. doi: 10.1016/s1357-4310(98)01265-9. Mol Med Today. 1998. PMID: 9743990 Review.
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial.
Alton EW, Stern M, Farley R, Jaffe A, Chadwick SL, Phillips J, Davies J, Smith SN, Browning J, Davies MG, Hodson ME, Durham SR, Li D, Jeffery PK, Scallan M, Balfour R, Eastman SJ, Cheng SH, Smith AE, Meeker D, Geddes DM. Alton EW, et al. Among authors: davies mg, davies j. Lancet. 1999 Mar 20;353(9157):947-54. doi: 10.1016/s0140-6736(98)06532-5. Lancet. 1999. PMID: 10459902 Clinical Trial.
Gene therapy for cystic fibrosis.
Davies JC, Geddes DM, Alton EW. Davies JC, et al. J Gene Med. 2001 Sep-Oct;3(5):409-17. doi: 10.1002/jgm.200. J Gene Med. 2001. PMID: 11601754 Review.
Airway surface pH in subjects with cystic fibrosis.
McShane D, Davies JC, Davies MG, Bush A, Geddes DM, Alton EW. McShane D, et al. Among authors: davies mg, davies jc. Eur Respir J. 2003 Jan;21(1):37-42. doi: 10.1183/09031936.03.00027603. Eur Respir J. 2003. PMID: 12570106 Free article.
Modifier genes in cystic fibrosis.
Davies JC, Griesenbach U, Alton E. Davies JC, et al. Pediatr Pulmonol. 2005 May;39(5):383-91. doi: 10.1002/ppul.20198. Pediatr Pulmonol. 2005. PMID: 15765543 Review.
Exploring the mechanisms of macrolides in cystic fibrosis.
Equi AC, Davies JC, Painter H, Hyde S, Bush A, Geddes DM, Alton EW. Equi AC, et al. Respir Med. 2006 Apr;100(4):687-97. doi: 10.1016/j.rmed.2005.07.016. Epub 2005 Sep 26. Respir Med. 2006. PMID: 16185859 Free article.
7,385 results